Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcus Biosciences (RCUS) Revenue (2017 - 2025)

Historic Revenue for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to $26.0 million.

  • Arcus Biosciences' Revenue fell 4583.33% to $26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $240.0 million, marking a year-over-year decrease of 874.52%. This contributed to the annual value of $258.0 million for FY2024, which is 12051.28% up from last year.
  • Arcus Biosciences' Revenue amounted to $26.0 million in Q3 2025, which was down 4583.33% from $160.0 million recorded in Q2 2025.
  • In the past 5 years, Arcus Biosciences' Revenue registered a high of $354.6 million during Q4 2021, and its lowest value of $9.5 million during Q1 2021.
  • Its 5-year average for Revenue is $57.1 million, with a median of $29.0 million in 2023.
  • As far as peak fluctuations go, Arcus Biosciences' Revenue surged by 363792.56% in 2021, and later crashed by 9041.22% in 2022.
  • Over the past 5 years, Arcus Biosciences' Revenue (Quarter) stood at $354.6 million in 2021, then plummeted by 90.41% to $34.0 million in 2022, then dropped by 8.82% to $31.0 million in 2023, then dropped by 16.13% to $26.0 million in 2024, then changed by 0.0% to $26.0 million in 2025.
  • Its Revenue was $26.0 million in Q3 2025, compared to $160.0 million in Q2 2025 and $28.0 million in Q1 2025.